The Current Challenges in Developing Biological and Clinical Predictors of Congenital Cytomegalovirus Infection

Int J Mol Sci. 2021 Dec 15;22(24):13487. doi: 10.3390/ijms222413487.

Abstract

Congenital cytomegalovirus (CMV) infection may cause severe long-term sequelae. Recent studies have demonstrated that early antiviral therapy for infants with symptomatic congenital CMV (cCMV) infection may improve neurological outcomes; thus, accurate identification of newborns at high risk of cCMV infection may contribute to improved outcomes in affected children. However, maternal serological screening for cCMV infection by diagnosing primary infection during pregnancy, which is a popular screening strategy, is inefficient, because the number of cCMV infections with nonprimary causes, including reactivation of or reinfection with CMV, is larger than that of cCMV infections with primary causes. Low levels of neutralizing antibodies against pentameric complex and potent CMV-specific T cell-mediated immune responses are associated with an increased risk of cCMV infection. Conversely, our prospective cohort studies revealed that the presence of maternal fever/flu-like symptoms, threatened miscarriage/premature delivery, or actual premature delivery are risk factors for cCMV infection among both women with normal pregnancies and those with high-risk ones, regardless of whether the infection is primary or nonprimary. This review focused on host immune responses to human CMV and current knowledge of potential biological and clinical factors that are predictive of cCMV infection.

Keywords: T cell-mediated immune response; clinical risk factor; congenital cytomegalovirus infection; neutralizing antibodies; nonprimary infection; prediction; primary infection; screening.

Publication types

  • Review

MeSH terms

  • Cohort Studies
  • Cytomegalovirus / immunology
  • Cytomegalovirus / pathogenicity
  • Cytomegalovirus Infections / epidemiology*
  • Cytomegalovirus Infections / immunology*
  • DNA, Viral
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Infectious Disease Transmission, Vertical / statistics & numerical data
  • Male
  • Pregnancy
  • Pregnancy Complications, Infectious / diagnosis
  • Prognosis
  • Prospective Studies
  • Risk Factors

Substances

  • DNA, Viral